Founded in 2001, Genstruct is a therapeutic mechanism discovery company that has developed a platform for compound mechanism of action (MOA) and biomarker discovery called Molecular Epistemics. This platform is comprised of two core technologies that enable the modeling and analysis of compound MOA, Knowledge Assembly and the Epistemics Engine. Genstruct is developing discovery and development partnerships that apply Molecular Epistemics to accelerate discovery and approval and increase the output of drug discovery and development programs. The Company was co-founded by Flagship Ventures, based in Cambridge, MA.

Genstruct changed the company name to Selventa in November 2010.